These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 13525162)

  • 1. Treatment of anticholinesterase intoxication with oximes; use in normal subjects and in patients with myasthenia gravis.
    GROB D; JOHNS RJ
    J Am Med Assoc; 1958 Apr; 166(15):1855-8. PubMed ID: 13525162
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of oximes in the treatment of intoxication by anticholinesterase compounds in patients with myasthenia gravis.
    GROB D; JOHNS RJ
    Am J Med; 1958 Apr; 24(4):512-8. PubMed ID: 13520752
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of anticholinesterase intoxication with oximes.
    GROB D; JOHNS RJ
    Neurology; 1958 Dec; 8(12):897-902. PubMed ID: 13613472
    [No Abstract]   [Full Text] [Related]  

  • 4. The long-acting anticholinesterase drugs in the management of myasthenia gravis.
    ARANOW H; HOEFER PF; ROWLAND LP
    J Chronic Dis; 1957 Nov; 6(5):457-74. PubMed ID: 13475447
    [No Abstract]   [Full Text] [Related]  

  • 5. Local administration of anticholinesterase agents in ocular myasthenia gravis.
    LEOPOLD IH; HEDGES TR; MONTANA J; KRISHNA N; BECKETT S
    Arch Ophthalmol; 1960 Mar; 63():544-7. PubMed ID: 14415845
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation local ocular anticholinesterase agents in myasthenia gravis.
    GILES CL; WESTERBERG MR
    Am J Ophthalmol; 1961 Sep; 52():331-40. PubMed ID: 13705283
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the mechanism of action of some anticholinesterase preparations].
    PEREL'MAN LB; PRIKHOZHAN VM; MATLINA ESh
    Biull Eksp Biol Med; 1962 May; 53():76-80. PubMed ID: 14485240
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological studies of cholinesterase reactivating oximes. An evaluation of their use in anticholinesterase poisoning.
    SUNDWALL A
    Tidskr Mil Halsov; 1961; 86():351-81. PubMed ID: 13918437
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electroencephalographic aspects of the antagonism between 2-pyridine aldoxime iodomethylate (PAM) and isopropyl methylfluorophosphate (sarin)].
    LONGO VG; NACHMANSOHN D; BOVET D
    Arch Int Pharmacodyn Ther; 1960 Jan; 123():282-90. PubMed ID: 14418175
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood cholinesterase during the treatment of myasthenia by anti-cholinesterase drugs (prostigmine and mestinon)].
    VINCENT D; PLANQUES J; GERAUD J; DARDENNE P
    Therapie; 1960; 15():906-13. PubMed ID: 13781449
    [No Abstract]   [Full Text] [Related]  

  • 11. Oximes and hydroxamic acids as antidotes in anticholinesterase poisoning.
    ASKEW BM
    Br J Pharmacol Chemother; 1956 Dec; 11(4):417-23. PubMed ID: 13383120
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of juvenile myasthenia gravis.
    Ionita CM; Acsadi G
    Pediatr Neurol; 2013 Feb; 48(2):95-104. PubMed ID: 23337001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of myasthenia gravis: an audit.
    Simpson JA; Thomaides T
    Q J Med; 1987 Aug; 64(244):693-704. PubMed ID: 3328214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies in neuromuscular function. VI. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in patients with myasthenia gravis.
    GROB D; HARVEY AM; JOHNS RJ
    Bull Johns Hopkins Hosp; 1956 Oct; 99(4):219-38. PubMed ID: 13364533
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis.
    Lang AE; Humphrey JG; Gordn DA
    J Rheumatol; 1981; 8(2):303-7. PubMed ID: 7230162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinolytics in the treatment of anticholinesterase poisoning. II. Treatment of sarin poisoning with an oxime and various combinations of cholinolytic compounds.
    COLEMAN IW; LITTLE PE; BANNARD RA
    Rep Can Def Res Kings Lab; 1961 Oct; 100():13p. PubMed ID: 13880472
    [No Abstract]   [Full Text] [Related]  

  • 17. Essentials in the management of myasthenia gravis.
    Galdi AP
    Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis. A well-understood neuromuscular disorder.
    Ravits J
    Postgrad Med; 1988 Jan; 83(1):219-23. PubMed ID: 3336605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long term experience of thymectomy for myasthenia gravis.
    Scadding GK; Havard CW; Lange MJ; Domb I
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):401-6. PubMed ID: 3998750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinesterase abuse in myasthenia gravis.
    Munsat TL
    J Neurol Sci; 1984 Apr; 64(1):5-10. PubMed ID: 6376715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.